Search Results - "Sinniger, V."

Refine Results
  1. 1

    Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease by Bonaz, B., Sinniger, V., Pellissier, S.

    Published in Journal of internal medicine (01-07-2017)
    “…Inflammatory bowel disease (IBD), that is Crohn's disease (CD) and ulcerative colitis, affects about 1.5 million persons in the USA and 2.2 million in Europe…”
    Get full text
    Journal Article
  2. 2

    Chronic vagus nerve stimulation in Crohn's disease: a 6‐month follow‐up pilot study by Bonaz, B., Sinniger, V., Hoffmann, D., Clarençon, D., Mathieu, N., Dantzer, C., Vercueil, L., Picq, C., Trocmé, C., Faure, P., Cracowski, J‐L., Pellissier, S.

    Published in Neurogastroenterology and motility (01-06-2016)
    “…The vagus nerve (VN) is a link between the brain and the gut. The VN is a mixed nerve with anti‐inflammatory properties through the activation of the…”
    Get full text
    Journal Article
  3. 3

    Vagal tone: effects on sensitivity, motility, and inflammation by Bonaz, B., Sinniger, V., Pellissier, S.

    Published in Neurogastroenterology and motility (01-04-2016)
    “…The vagus nerve (VN) is a key element of the autonomic nervous system. As a mixed nerve, the VN contributes to the bidirectional interactions between the brain…”
    Get full text
    Journal Article
  4. 4

    Vagus nerve stimulation: from epilepsy to the cholinergic anti‐inflammatory pathway by Bonaz, B., Picq, C., Sinniger, V., Mayol, J. F., Clarençon, D.

    Published in Neurogastroenterology and motility (01-03-2013)
    “…Background  The brain and the gut communicate bidirectionally through the autonomic nervous system (ANS). The vagus nerve (VN), a major component of the ANS,…”
    Get full text
    Journal Article
  5. 5

    Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease by Meregnani, J, Clarençon, D, Vivier, M, Peinnequin, A, Mouret, C, Sinniger, V, Picq, C, Job, A, Canini, F, Jacquier-Sarlin, M, Bonaz, Bruno

    Published in Autonomic neuroscience (24-02-2011)
    “…Abstract Vagus nerve stimulation of afferents is used as an adjunctive treatment for drug-resistant epilepsy and depression. In addition, anti-inflammatory…”
    Get full text
    Journal Article
  6. 6

    Literature review of transcutaneous electrical nerve stimulation in peripheral arterial occlusive disease of the lower limbs by Blaise, S., Sinniger, V., Seinturier, C.

    Published in Journal de médecine vasculaire (01-09-2023)
    “…The therapeutic challenge in peripheral arterial occlusive disease (PAD) is often to increase walking distance, improve pain or heal a wound when PAD is…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Fedotozine, a kappa‐opioid agonist, prevents spinal and supra‐spinal Fos expression induced by a noxious visceral stimulus in the rat by Bonaz, Rivière, Sinniger, Pascaud, Junien, Fournet, Feuerstein

    Published in Neurogastroenterology and motility (01-04-2000)
    “…Fedotozine, a kappa opioid agonist, reverses digestive ileus caused by acetic acid (AA)‐induced visceral pain in rats. The aims of this study were: to map, in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification by Sinniger, V, Tapon-Bretaudière, J, Zhou, F L, Bros, A, Muller, D, Jozefonvicz, J, Fischer, A M

    Published in Journal of chromatography (1991)
    “…Dermatan sulphate (DS) is a glycosaminoglycan which catalyses specifically thrombin inhibition by a plasmatic inhibitor, Heparin cofactor II (HCII). DS was…”
    Get more information
    Journal Article
  15. 15

    c-fos and CRF receptor gene transcription in the brain of acetic acid-induced somato-visceral pain in rats by Sinniger, Valérie, Porcher, Christophe, Mouchet, Patrick, Juhem, Aurélie, Bonaz, Bruno

    Published in Pain (Amsterdam) (01-08-2004)
    “…We aimed to characterize neuronal and corticotrophin-releasing (CRF) pathways in a model of somato-visceral pain in rats. Male rats received an intraperitoneal…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Regulation of tissue plasminogen activator activity by cells. Domains responsible for binding and mechanism of stimulation by Sinniger, V, Merton, R E, Fabregas, P, Felez, J, Longstaff, C

    Published in The Journal of biological chemistry (30-04-1999)
    “…A number of cell types have previously been shown to bind tissue plasminogen activator (tPA), which in some cases can remain active on the cell surface…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    A comparison of cultured cells with other promoters of tissue plasminogen activator kinetics by Longstaff, C., Merton, R.E., Sinniger, V.

    Published in Fibrinolysis (01-05-1995)
    “…Single chain tissue plasminogen activator (sctPA) is not a zymogen form of two chain tPA (tctPA) but its activity can be enhanced by this conversion (by…”
    Get full text
    Journal Article